Exploring biomarkers and therapeutic targets for pressure overload induced heart failure based on microarray data

Area of Science:

• Molecular Biology
• Genomics
• Cardiovascular Research

Background:

• Heart failure (HF) is a severe condition with significant healthcare costs and a poor prognosis.
• Decades of research have focused on understanding HF mechanisms and developing effective treatments.

Purpose of the Study:

• To identify differentially expressed RNAs in a pressure overload-induced heart failure mouse model.
• To explore potential biomarkers and therapeutic targets for heart failure.

Main Methods:

• Established a mouse model of heart failure using transaortic arch constriction (TAC).
• Performed global expression profiling of long noncoding RNAs (lncRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) using microarrays and quantitative PCR (qPCR).
• Utilized bioinformatics analyses, including Gene Ontology (GO), pathway enrichment, and competing endogenous RNA (ceRNA) network construction.

Main Results:

• Identified 1,139 differentially expressed mRNAs, 3,830 lncRNAs, and 13 miRNAs in the HF group compared to controls.
• Enrichment analyses revealed involvement of pathways like extracellular matrix structural constituent and integrin signaling in HF pathogenesis.
• Constructed a ceRNA network with nine DElncRNAs, three DEmiRNAs, and 25 DEmRNAs, highlighting their regulatory roles and therapeutic potential.

Conclusions:

• Identified specific differentially expressed RNAs implicated in heart failure pathogenesis and progression.
• Provided insights into the underlying molecular mechanisms of HF.
• Highlighted candidate biomarkers and potential intervention targets for future heart failure research.